EMJ GOLD - European Medical Journal

Pharma News, Views & Analysis

Filter Advertise With Us

An illustration of two people's hands shaking, wearing suits

Roche acquires US biotech 89bio for $3.5bn

Roche is acquiring US-based biotech 89bio in a deal worth up to $3.5 billion, bolstering its pipeline with a late-stage therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH).

Could psychedelic medicine solve the mental health crisis?

Explore the evolving role of MDMA, LSD and psilocybin in traditional medical research, particularly in the realm of mental health.

Illustrated handshake

BMS appoints new EVP, CMO and Head of Development

Bristol Myers Squibb announces the appointment of Dr Cristian Massacesi as Executive Vice President, Chief Medical Officer and Head of Development.

A colourful flat illustration of a woman looking into a microscope

Daiichi Sankyo’s Laura McMullin appointed ABPI Vice President

Laura McMullin, General Manager, Daiichi Sankyo UK, has been appointed the new Vice President of the ABPI.

WHO: Unequal vaccine rates put children at risk

WHO and UNICEF report finds that global childhood vaccination coverage held steady in 2024, but that worrying gaps remain.

Survey shows pharma leaders backing AI and RWD

A new survey has found that the use of AI and real-world data (RWD) is on the rise across the biopharma industry, but hurdles remain.

Award spotlights role of genomics in conservation

While genomics is best known for its role advancing precision medicine, MGI Tech has pioneered a new use case in enviromental sustainability.

UNAIDS: AIDS response at risk from funding cuts

UNAIDS report warns the US funding collapse could risk millions of new infections and deaths unless countries transform their HIV responses.

Sanofi returns as sponsor of British Transplant Games

Sanofi is sponsoring the event for the second year in a row, which brings together 1,000 transplant recipients and live donors to compete.

Loading posts...

« Previous 1 2 3 4 5 6 … 34 Next »